Gilead breaks ground on Foster City biologics facility in $32 billion US investment push
GILD•Gilead breaks ground on Foster City biologics facility
Gilead broke ground on its Chess biologics facility at its Foster City, California headquarters as part of a planned $32 billion U.S. investment through 2030.
The site targets expanded end-to-end biologics capacity, aiming to speed development from clinical work to commercial launch.
Completion is expected in 2029.
